98%
921
2 minutes
20
Dual-drug delivery systems using hydrogel-nanoparticle composites have emerged as a versatile platform for achieving controlled, targeted, and efficient delivery of two distinct therapeutic agents. This approach combines the high loading capacity and tunable release properties of hydrogels with the enhanced stability and targeting ability of nanoparticles, providing synergistic benefits in various biomedical applications. While significant progress has been made, previous research has primarily focused on single-drug systems or simple co-delivery strategies, often lacking precise spatial and temporal control. This gap underscores the need for more sophisticated composite designs that enable programmable, multi-phase release. This review discusses representative fabrication methods, including physical embedding, covalent integration, and layer-by-layer assembly, to offer insights into practical implementation strategies. Also we present recent studies focusing on key applications-including wound healing, cancer therapy, infection prevention, transplant immunosuppression, and tissue regeneration-with an emphasis on composite design and formulation strategies, types of hydrogels and nanoparticles, and mechanisms of dual-drug release and evaluation. Recent advances in nanoparticle engineering and hydrogel formulation have enabled precise control over drug release and improved therapeutic outcomes. Dual-drug delivery systems using hydrogel-nanoparticle composites present a promising approach for overcoming the limitations of conventional monotherapy and achieving synergistic therapeutic effects. Ongoing research continues to optimize the design, efficacy, and safety of these systems, paving the way for their clinical translation.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC12294678 | PMC |
http://dx.doi.org/10.3390/gels11070520 | DOI Listing |
Mater Today Bio
October 2025
School of Public Health, Key Laboratory of Emergency and Trauma of Ministry of Education, Hainan Medical University, Haikou, 571199, China.
The development of controllable nanoplatforms with disease-specific responsiveness and programmable therapeutic functions is vital for treating complex cardiovascular diseases such as atherosclerosis. Herein, we present an intelligent, next-generation nanoplatform (HALA@AgS) that integrates enzyme-responsive dual-drug delivery with NIR-II imaging-guided photothermal therapy (PTT), enabling triple-stimuli synergy of enzyme, light, and multi-drug co-activation. This modular design enables stable nanoassemblies with high drug-loading capacity and selective disassembly in enzyme-rich plaque microenvironments, achieving controlled dual-drug release exceeding 80 % within 72 h.
View Article and Find Full Text PDFInt J Biol Macromol
September 2025
Crystal Growth Centre, Anna University, Chennai, 600025, Tamil Nadu, India.
Increase in breast cancer has led to the search for systems that can enable, targeted, sustained and prolonged release of drugs while simultaneously reducing the side effects posed by them. In light of this, folic acid-conjugated 5-Fluorouracil and doxorubicin loaded chitosan/Fe₃O₄ (FA-dual@CS/Fe₃O₄) nanocomposite has been synthesized using the chemical method for targeted breast cancer therapy in addition to CS/FeO and dual drug encapsulated CS/FeO. FTIR and XPS studies confirm the successful drug encapsulation and FA conjugation.
View Article and Find Full Text PDFInt J Biol Macromol
September 2025
School of Science, Technology and Engineering, University of the Sunshine Coast, Petrie, Queensland, Australia.
Drug release using polymeric microneedles (MNs) plays a significant role in medical applications and the treatment of various diseases. However, conventional MNs are often limited by complex fabrication procedures and inadequate mechanical strength. This study introduces a dual-function core/shell MN patch fabricated through a novel method that integrates 3D printing and casting techniques.
View Article and Find Full Text PDFACS Infect Dis
September 2025
The Department of Pharmaceutics of TCM (The High Educational Key Laboratory of Guizhou Province for Natural Medicinal Pharmacology and Druggability, the Union Key Laboratory of Guiyang City-Guizhou Medical University), School of Pharmaceutical Sciences, Guizhou Medical University, Guian New District
Methicillin-resistant (MRSA)-induced pneumonia has become a major global public health challenge due to its high mortality and drug resistance. Essential oils, derived from plants, offer a promising solution to combat resistance owing to their low cytotoxicity and multitarget antimicrobial properties. This study designed a phenylboronic acid (PBA)-functionalized liposomal codelivery system (P-Lip@CE) to reverse MRSA resistance by synergistically delivering cefazolin sodium (Cefas) and essential oil (EOFAZ).
View Article and Find Full Text PDFInt J Biol Macromol
August 2025
Department of Biomedical Engineering, Faculty of Chemical Engineering, Tarbiat Modares University, Tehran, Iran.
Among nanoparticles, polymersomes have drawn notable interest due to their ability to simultaneously load two drugs, their suitable size, high stability, and controlled drug release. In this study, an amphiphilic, redox-sensitive hyaluronic acid-polycaprolactone block copolymer was synthesized for targeted drug delivery to CD44-overexpressing breast cancer MDA-MB-231 cells. Nanopolymersomes were formed via nanoprecipitation and co-loaded with curcumin and methotrexate.
View Article and Find Full Text PDF